Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
The Korean Journal of Internal Medicine ; : 98-102, 2012.
Artículo en Inglés | WPRIM | ID: wpr-181910

RESUMEN

Bisphosphonates are potent inhibitors of bone resorption and widely used to treat osteoporosis. Extensive studies have shown that therapy with bisphosphonates improves bone density and decreases fracture risk. However, concerns have been raised about potential over-suppression of bone turnover during long-term use of bisphosphonates, resulting in increased susceptibility to and delayed healing of non-spinal fractures. We report a patient who sustained non-traumatic stress fractures in bilateral femoral shafts with delayed healing after long-term bisphosphonate therapy. She underwent open reduction and surgical internal fixation. Although bisphosphonates effectively prevent vertebral fractures, and their safety has been tested in randomized trials, we must emphasize the need for awareness of the possibility that long-term suppression of bone turnover with bisphosphonates may eventually lead to an accumulation of fatigue-induced damage and adverse skeletal effects such as delayed fracture healing.


Asunto(s)
Femenino , Humanos , Persona de Mediana Edad , Densidad Ósea/efectos de los fármacos , Diáfisis/efectos de los fármacos , Difosfonatos/efectos adversos , Fracturas del Fémur/inducido químicamente , Fijación Interna de Fracturas , Curación de Fractura/efectos de los fármacos , Fracturas Espontáneas/inducido químicamente , Fracturas por Estrés/inducido químicamente , Osteoporosis/tratamiento farmacológico , Radiofármacos , Medronato de Tecnecio Tc 99m/análogos & derivados , Resultado del Tratamiento , Imagen de Cuerpo Entero
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA